TY - JOUR
T1 - Beyond the Classical Triad
T2 - Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients
AU - Yaz, Ismail
AU - Oskay Halacli, Sevil
AU - Ipsir, Canberk
AU - Ulum, Baris
AU - Soyak Aytekin, Elif
AU - Bildik, Hacer Neslihan
AU - Ocak, Melike
AU - Avci, Hanife
AU - Okur, Fatma Visal
AU - Hizarcioglu Gulsen, Hayriye
AU - Demir, Hulya
AU - Metin, Ayse
AU - Ozon, Alev
AU - Kuskonmaz, Baris
AU - Tezcan, Ilhan
AU - Esenboga, Saliha
AU - Cagdas, Deniz
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/10/21
Y1 - 2025/10/21
N2 - Background Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked(IPEX) syndrome caused by FOXP3 mutations is rare. FOXP3 is a transcription factor required for the regulatory T cell (Treg) development/function. Aim We aimed to characterize the clinical, immunologic, and genetic features of a single-center cohort of IPEX syndrome. Patients and Methods We present the clinical/immunological/genetic features of 12 patients with IPEX syndrome. We used whole exome and Sanger sequencing for the diagnosis/familial segregation. We performed immunophenotyping and measured Treg percentage and FOXP3 expression in peripheral blood by flow cytometric analysis. Results Median age at diagnosis was 2.5 years (range: 0.3-22 years). Common clinical manifestations were infections (n = 9, 75%), allergies (n = 8, 67%), autoimmunity (n = 7, 58%), enteropathy (n = 7, 58%), and lymphoproliferation (n = 3, 25%). Atypical initial presentations included class IV lupus nephritis, a SCID-like immunophenotype (CD3(+) T cells: 4% [100/mu L]; CD4(+) T cells: 3%, CD8(+) T cells: 1%, CD19(+) B cells: 81%, CD16/56(+) NK cells: 13%), and isolated hypogammaglobulinemia persisting for years during follow-up. At the time of diagnosis, three (25%) patients had leukopenia, six (50%) had lymphopenia and two (17%) had neutropenia. Eosinophilia was observed in 42% of patients (25% mild, 17% moderate). Six different variants in FOXP3 were characterized in 12 patients from nine unrelated families. Four (33%) patients underwent hematopoietic stem cell transplantation (HSCT). Overall, three (25%) patients died due to infections. One patient died due to HSCT-related catheter complications, one patient died in an accident. Among the transplanted patients, two are alive and well. Among the non-transplanted patients, five are alive and are being followed up at our center. Treg (CD4(+)CD127(-/low)CD25(+)Foxp3(+)) percentage was low in eight patients compared to healthy controls (p < 0.001). FOXP3 expression was low in all the patients compared to healthy controls. Conclusion Atypical presentations make the diagnosis of IPEX syndrome challenging. This study expands the current knowledge of IPEX syndrome by describing a single-center cohort with certain atypical manifestations and by confirming previously reported rare phenotypes. Elucidating the genetic basis of immunodeficiency diseases contributes to improving diagnostic approaches and patient management.
AB - Background Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked(IPEX) syndrome caused by FOXP3 mutations is rare. FOXP3 is a transcription factor required for the regulatory T cell (Treg) development/function. Aim We aimed to characterize the clinical, immunologic, and genetic features of a single-center cohort of IPEX syndrome. Patients and Methods We present the clinical/immunological/genetic features of 12 patients with IPEX syndrome. We used whole exome and Sanger sequencing for the diagnosis/familial segregation. We performed immunophenotyping and measured Treg percentage and FOXP3 expression in peripheral blood by flow cytometric analysis. Results Median age at diagnosis was 2.5 years (range: 0.3-22 years). Common clinical manifestations were infections (n = 9, 75%), allergies (n = 8, 67%), autoimmunity (n = 7, 58%), enteropathy (n = 7, 58%), and lymphoproliferation (n = 3, 25%). Atypical initial presentations included class IV lupus nephritis, a SCID-like immunophenotype (CD3(+) T cells: 4% [100/mu L]; CD4(+) T cells: 3%, CD8(+) T cells: 1%, CD19(+) B cells: 81%, CD16/56(+) NK cells: 13%), and isolated hypogammaglobulinemia persisting for years during follow-up. At the time of diagnosis, three (25%) patients had leukopenia, six (50%) had lymphopenia and two (17%) had neutropenia. Eosinophilia was observed in 42% of patients (25% mild, 17% moderate). Six different variants in FOXP3 were characterized in 12 patients from nine unrelated families. Four (33%) patients underwent hematopoietic stem cell transplantation (HSCT). Overall, three (25%) patients died due to infections. One patient died due to HSCT-related catheter complications, one patient died in an accident. Among the transplanted patients, two are alive and well. Among the non-transplanted patients, five are alive and are being followed up at our center. Treg (CD4(+)CD127(-/low)CD25(+)Foxp3(+)) percentage was low in eight patients compared to healthy controls (p < 0.001). FOXP3 expression was low in all the patients compared to healthy controls. Conclusion Atypical presentations make the diagnosis of IPEX syndrome challenging. This study expands the current knowledge of IPEX syndrome by describing a single-center cohort with certain atypical manifestations and by confirming previously reported rare phenotypes. Elucidating the genetic basis of immunodeficiency diseases contributes to improving diagnostic approaches and patient management.
KW - Adolescent
KW - Adult
KW - Child
KW - Child, Preschool
KW - Cohort Studies
KW - Diabetes Mellitus, Type 1/genetics
KW - Diarrhea/congenital
KW - Female
KW - Forkhead Transcription Factors/genetics
KW - Genetic Diseases, X-Linked/diagnosis
KW - Humans
KW - Immune System Diseases/congenital
KW - Immunophenotyping
KW - Infant
KW - Male
KW - Mutation
KW - Phenotype
KW - T-Lymphocytes, Regulatory/immunology
KW - Young Adult
UR - https://www.scopus.com/pages/publications/105019343074
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:001598185400001&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1007/s10875-025-01934-7
DO - 10.1007/s10875-025-01934-7
M3 - Article
C2 - 41117878
AN - SCOPUS:105019343074
SN - 0271-9142
VL - 45
SP - 148
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
IS - 1
M1 - 148
ER -